Immuneering Corporation Increase Decrease In Operating Lease Liability
Immuneering Corporation (IMRX) reported Increase Decrease In Operating Lease Liability of -$190.82 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-05
- Immuneering Corporation increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$96.60K.
- Immuneering Corporation increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$94.22K.
- Immuneering Corporation increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$91.90K.
- Immuneering Corporation increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$84.23K.
- Immuneering Corporation increase decrease in operating lease liability for fiscal 2025 was -$338.43K.
- Immuneering Corporation increase decrease in operating lease liability for fiscal 2024 was -$300.10K.
- Immuneering Corporation increase decrease in operating lease liability for fiscal 2023 was -$378.72K.
- Immuneering Corporation increase decrease in operating lease liability for fiscal 2022 was -$126.38K.
| Period end | Increase Decrease In Operating Lease Liability 1 month | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$96.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$190.82K 10-Q · filed 2026-08-05 | -$282.72K derived: sum of 3 quarters · filed 2026-08-05 | -$366.95K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | -$94.22K 10-Q · filed 2026-05-15 | -$186.13K derived: sum of 2 quarters · filed 2026-05-15 | -$270.36K derived: sum of 3 quarters · filed 2026-05-15 | -$352.51K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | -$91.90K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$176.13K derived: sum of 2 quarters · filed 2026-03-06 | -$258.29K derived: sum of 3 quarters · filed 2026-08-05 | -$338.43K 10-K · filed 2026-03-06 | |
| 2025-09-30 | -$84.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$166.39K derived: sum of 2 quarters · filed 2026-08-05 | -$246.53K 10-Q · filed 2025-11-12 | -$324.70K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | -$82.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$162.30K 10-Q · filed 2026-08-05 | -$240.47K derived: sum of 3 quarters · filed 2026-08-05 | -$311.45K derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | -$80.14K 10-Q · filed 2026-05-15 | -$158.31K derived: sum of 2 quarters · filed 2026-05-15 | -$229.29K derived: sum of 3 quarters · filed 2026-05-15 | -$298.54K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$78.17K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$149.16K derived: sum of 2 quarters · filed 2026-03-06 | -$218.40K derived: sum of 3 quarters · filed 2026-03-06 | -$300.10K 10-K · filed 2026-03-06 | |
| 2024-09-30 | -$70.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$140.23K derived: sum of 2 quarters · filed 2025-11-12 | -$221.93K 10-Q · filed 2025-11-12 | -$301.63K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | -$69.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$150.95K 10-Q · filed 2025-08-13 | -$230.64K derived: sum of 3 quarters · filed 2025-08-13 | -$332.67K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | -$81.70K 10-Q · filed 2025-05-05 | -$161.40K derived: sum of 2 quarters · filed 2025-05-05 | -$263.43K derived: sum of 3 quarters · filed 2025-05-05 | -$363.23K derived: sum of 4 quarters · filed 2025-05-05 | |
| 2023-12-31 | -$79.69K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$181.72K derived: sum of 2 quarters · filed 2025-03-20 | -$281.53K derived: sum of 3 quarters · filed 2025-03-20 | -$378.72K 10-K · filed 2025-03-20 | |
| 2023-09-30 | -$102.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$201.84K derived: sum of 2 quarters · filed 2024-11-13 | -$299.03K 10-Q · filed 2024-11-13 | -$308.69K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | -$99.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$197.00K 10-Q · filed 2024-08-06 | -$206.66K derived: sum of 3 quarters · filed 2024-08-06 | -$237.24K derived: sum of 4 quarters · filed 2024-08-06 | |
| 2023-03-31 | -$97.19K 10-Q · filed 2024-05-07 | -$106.86K derived: sum of 2 quarters · filed 2024-05-07 | -$137.43K derived: sum of 3 quarters · filed 2024-05-07 | -$179.32K derived: sum of 4 quarters · filed 2024-05-07 | |
| 2022-12-31 | -$9.66K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$40.24K derived: sum of 2 quarters · filed 2024-03-01 | -$82.13K derived: sum of 3 quarters · filed 2024-03-01 | -$126.38K 10-K · filed 2024-03-01 | |
| 2022-09-30 | -$30.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$72.47K derived: sum of 2 quarters · filed 2023-11-09 | -$116.72K 10-Q · filed 2023-11-09 | -$141.24K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | -$41.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$86.14K 10-Q · filed 2023-08-03 | -$110.67K derived: sum of 3 quarters · filed 2023-08-03 | -$129.72K derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | -$44.25K 10-Q · filed 2023-05-04 | -$68.78K derived: sum of 2 quarters · filed 2023-05-04 | -$87.83K derived: sum of 3 quarters · filed 2023-05-04 | -$106.61K derived: sum of 4 quarters · filed 2023-05-04 | |
| 2022-01-31 | -$347.74K 10-Q · filed 2024-11-13 | ||||
| 2021-12-31 | -$24.52K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$43.58K derived: sum of 2 quarters · filed 2023-03-06 | -$62.36K derived: sum of 3 quarters · filed 2023-03-06 | -$80.85K 10-K · filed 2023-03-06 | |
| 2021-09-30 | -$19.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$37.83K derived: sum of 2 quarters · filed 2022-11-10 | -$56.33K 10-Q · filed 2022-11-10 | -$73.10K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$18.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$37.27K 10-Q · filed 2022-08-10 | -$54.05K derived: sum of 3 quarters · filed 2022-08-10 | -$64.27K derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | -$18.50K 10-Q · filed 2022-05-10 | -$35.27K derived: sum of 2 quarters · filed 2022-05-10 | -$45.49K derived: sum of 3 quarters · filed 2022-05-10 | ||
| 2020-12-31 | -$16.77K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$27.00K derived: sum of 2 quarters · filed 2022-03-10 | -$46.99K 10-K · filed 2022-03-10 | ||
| 2020-09-30 | -$10.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$30.22K 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | -$19.99K 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |